View in EDS

Health technology assessment reports for oncology medications in Canada from 2018 to 2025: methodological critiques on manufacturers' submissions and a comparison between manufacturers and Canada's Drug Agency (CDA) analyses.

Saved in:
Bibliographic Details
Title: Health technology assessment reports for oncology medications in Canada from 2018 to 2025: methodological critiques on manufacturers' submissions and a comparison between manufacturers and Canada's Drug Agency (CDA) analyses.
Authors: Mardani Jadid S; Health Research Department, Bright Health Science, Vaughan, Canada., Dokhaei M; Health Research Department, Bright Health Science, Vaughan, Canada., Dini N; Health Research Department, Bright Health Science, Vaughan, Canada., Tajadod M; Health Research Department, Bright Health Science, Vaughan, Canada., Azizi Khezri D; Health Research Department, Bright Health Science, Vaughan, Canada., Hariri K; Health Research Department, Bright Health Science, Vaughan, Canada., Levine M; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada.; Center for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Canada.; Programs for Assessment of Technology in Health (PATH), the Research Institute of St. Joe's Hamilton, St. Joseph's Healthcare, Hamilton, Canada., Mirzayeh Fashami F; Health Research Department, Bright Health Science, Vaughan, Canada.; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada.
Source: Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2026 Mar; Vol. 26 (3), pp. 451-463. Date of Electronic Publication: 2026 Feb 19.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101132257 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8379 (Electronic) Linking ISSN: 14737167 NLM ISO Abbreviation: Expert Rev Pharmacoecon Outcomes Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41680120
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Health technology assessment reports for oncology medications in Canada from 2018 to 2025: methodological critiques on manufacturers' submissions and a comparison between manufacturers and Canada's Drug Agency (CDA) analyses.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mardani+Jadid+S%22">Mardani Jadid S</searchLink>; Health Research Department, Bright Health Science, Vaughan, Canada.<br /><searchLink fieldCode="AU" term="%22Dokhaei+M%22">Dokhaei M</searchLink>; Health Research Department, Bright Health Science, Vaughan, Canada.<br /><searchLink fieldCode="AU" term="%22Dini+N%22">Dini N</searchLink>; Health Research Department, Bright Health Science, Vaughan, Canada.<br /><searchLink fieldCode="AU" term="%22Tajadod+M%22">Tajadod M</searchLink>; Health Research Department, Bright Health Science, Vaughan, Canada.<br /><searchLink fieldCode="AU" term="%22Azizi+Khezri+D%22">Azizi Khezri D</searchLink>; Health Research Department, Bright Health Science, Vaughan, Canada.<br /><searchLink fieldCode="AU" term="%22Hariri+K%22">Hariri K</searchLink>; Health Research Department, Bright Health Science, Vaughan, Canada.<br /><searchLink fieldCode="AU" term="%22Levine+M%22">Levine M</searchLink>; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada.; Center for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Canada.; Programs for Assessment of Technology in Health (PATH), the Research Institute of St. Joe's Hamilton, St. Joseph's Healthcare, Hamilton, Canada.<br /><searchLink fieldCode="AU" term="%22Mirzayeh+Fashami+F%22">Mirzayeh Fashami F</searchLink>; Health Research Department, Bright Health Science, Vaughan, Canada.; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101132257%22">Expert review of pharmacoeconomics & outcomes research</searchLink> [Expert Rev Pharmacoecon Outcomes Res] 2026 Mar; Vol. 26 (3), pp. 451-463. <i>Date of Electronic Publication: </i>2026 Feb 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Comparative Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101132257 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-8379 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214737167%22">14737167 </searchLink><i>NLM ISO Abbreviation: </i>Expert Rev Pharmacoecon Outcomes Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41680120
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/14737167.2026.2632265
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 451
    Titles:
      – TitleFull: Health technology assessment reports for oncology medications in Canada from 2018 to 2025: methodological critiques on manufacturers' submissions and a comparison between manufacturers and Canada's Drug Agency (CDA) analyses.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mardani Jadid S
      – PersonEntity:
          Name:
            NameFull: Dokhaei M
      – PersonEntity:
          Name:
            NameFull: Dini N
      – PersonEntity:
          Name:
            NameFull: Tajadod M
      – PersonEntity:
          Name:
            NameFull: Azizi Khezri D
      – PersonEntity:
          Name:
            NameFull: Hariri K
      – PersonEntity:
          Name:
            NameFull: Levine M
      – PersonEntity:
          Name:
            NameFull: Mirzayeh Fashami F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2026 Mar
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1744-8379
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Expert review of pharmacoeconomics & outcomes research
              Type: main
ResultId 1